Petition to Consolidate Mirena® IUD Lawsuits into Multidistrict Litigation (MDL) has been Filed, Parker Waichman LLP Reports

Share Article

Parker Waichman LLP reports that a petition has been filed for a Mirena® multidistrict litigation (MDL). A multidistrict litigation is created when there are a number of lawsuits with common questions of fact; in this case, Mirena® IUD lawsuits allege that the IUD is defective and can spontaneously migrate outside of the uterus, causing injuries.

News Image
The Plaintiff’s attorneys have filed a motion to transfer the cases to the U.S. District Court for the Northern District of Ohio, Eastern Division before the Honorable Patricia A. Gaughan.

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective medical devices, reports that a petition has been filed for a Mirena® IUD multidistrict litigation (In Re: Mirena IUD Product Liability Litigation, Case No. 1:12-CV-2780). The Plaintiff’s attorneys have filed a motion to transfer the cases to the U.S. District Court for the Northern District of Ohio, Eastern Division before the Honorable Patricia A. Gaughan.

A multidistrict litigation is created when complex litigation has common questions of fact. By centralizing the lawsuits in one court before one judge, pre-trial proceedings will be more efficient and duplicate findings will be avoided.

Mirena® was approved in 2000. Bayer’s Mirena® is an intrauterine device, or IUD; it is a contraceptive that is placed inside the uterus by a healthcare professional. The Mirena® IUD can remain in the body for up to five years. Mirena® is a hormonal IUD, and slowly releases the hormone levonorgestrel while implanted. According to the U.S. Food and Drug Administration (FDA), the most serious adverse events associated with the device since its time on the market include:

  •     Perforation of the uterine wall
  •     Embedment of the device in the uterine wall
  •     Ectopic pregnancy
  •     Intrauterine pregnancy
  •     Group A streptococcal sepsis
  •     Pelvic inflammatory disease (PID)

In 2009, Bayer was reprimanded by the Department of Health and Human Services’ Division of Drug Marketing, Advertising, and Communications (DDMAC) for overstating the benefits, while failing to mention the risks, of Mirena® in the company’s “Simple Style” program.

Matthew J. McCauley, Senior Litigation Counsel at Parker Waichman LLP, currently co-chairs the American Association for Justice-Mirena IUD Litigation Group.

Parker Waichman LLP continues to offer free lawsuit consultations to victims of Mirena® IUD birth control. If you or as a loved one experienced complications following the use of this device, please visit the firm's Mirena® IUD Side Effects page at yourlawyer.com. Free case evaluations are also available by calling 1 800 LAW INFO (1-800-529-4636).

Contact:    
Parker Waichman LLP
Gary P. Falkowitz, Managing Attorney
(800) LAW-INFO
(800) 529-4636
http://www.yourlawyer.com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Gary Falkowitz
Parker Waichman LLP
1-800-529-4636
Email >
Follow us on
Visit website